Literature DB >> 1871141

Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich "bubble" located within the rev-responsive region of viral mRNAs.

S Heaphy1, J T Finch, M J Gait, J Karn, M Singh.   

Abstract

The human immunodeficiency virus type 1 rev protein binds with high affinity (Kd less than 1-3 nM) to a purine-rich "bubble" containing bulged GG and GUA residues on either side of a double-helical RNA stem-loop located toward the 5' end of rev-response element RNA. High-affinity rev binding is maintained when the bubble is placed in heterologous stem-loop structures, but rev binding is reduced when either the bulged residues or flanking base pairs in the stem are altered. Rev binding to the purine-rich bubble nucleates assembly of long filamentous ribonucleoprotein structures containing polymers of rev bound to flanking RNA sequences. It is proposed that rev regulates human immunodeficiency virus RNA expression by selectively packaging viral transcripts carrying the rev-response element sequence into rod-like nucleoprotein complexes that block splicing of the packaged mRNAs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1871141      PMCID: PMC52296          DOI: 10.1073/pnas.88.16.7366

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids.

Authors:  H S Olsen; A W Cochrane; P J Dillon; C M Nalin; C A Rosen
Journal:  Genes Dev       Date:  1990-08       Impact factor: 11.361

2.  Human immunodeficiency virus rev protein recognizes a target sequence in rev-responsive element RNA within the context of RNA secondary structure.

Authors:  S M Holland; N Ahmad; R K Maitra; P Wingfield; S Venkatesan
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

3.  Effects of GA mismatches on the structure and thermodynamics of RNA internal loops.

Authors:  J SantaLucia; R Kierzek; D H Turner
Journal:  Biochemistry       Date:  1990-09-18       Impact factor: 3.162

4.  Rev-dependent expression of human immunodeficiency virus type 1 gp160 in Drosophila melanogaster cells.

Authors:  M Ivey-Hoyle; M Rosenberg
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

5.  Regulation by HIV Rev depends upon recognition of splice sites.

Authors:  D D Chang; P A Sharp
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

6.  Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev response element.

Authors:  J Kjems; M Brown; D D Chang; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

7.  Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice.

Authors:  J D McGhee; P H von Hippel
Journal:  J Mol Biol       Date:  1974-06-25       Impact factor: 5.469

8.  Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus.

Authors:  C A Rosen; E Terwilliger; A Dayton; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

9.  Purification and characterization of recombinant Rev protein of human immunodeficiency virus type 1.

Authors:  C M Nalin; R D Purcell; D Antelman; D Mueller; L Tomchak; B Wegrzynski; E McCarney; V Toome; R Kramer; M C Hsu
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

10.  A human cell factor is essential for HIV-1 Rev action.

Authors:  D Trono; D Baltimore
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

View more
  77 in total

1.  The Rev protein is able to transport to the cytoplasm small nucleolar RNAs containing a Rev binding element.

Authors:  S B Buonomo; A Michienzi; F G De Angelis; I Bozzoni
Journal:  RNA       Date:  1999-08       Impact factor: 4.942

Review 2.  Half a century of "the nuclear matrix".

Authors:  T Pederson
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

3.  Polyvalent Rev decoys act as artificial Rev-responsive elements.

Authors:  T L Symensma; S Baskerville; A Yan; A D Ellington
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

4.  Binding of Xenopus oocyte masking proteins to mRNA sequences.

Authors:  K Marello; J LaRovere; J Sommerville
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

5.  Specific binding of the human T-cell leukemia virus type I Rex protein to a short RNA sequence located within the Rex-response element.

Authors:  H P Bogerd; L S Tiley; B R Cullen
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

6.  Structural and functional analysis of the visna virus Rev-response element.

Authors:  L S Tiley; B R Cullen
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

7.  trans-dominant inhibition of human immunodeficiency virus type 1 Rev occurs through formation of inactive protein complexes.

Authors:  T J Hope; N P Klein; M E Elder; T G Parslow
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

8.  HIV Rev response element (RRE) directs assembly of the Rev homooligomer into discrete asymmetric complexes.

Authors:  Matthew D Daugherty; David S Booth; Bhargavi Jayaraman; Yifan Cheng; Alan D Frankel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

9.  Dynamics of the human and viral m(6)A RNA methylomes during HIV-1 infection of T cells.

Authors:  Gianluigi Lichinchi; Shang Gao; Yogesh Saletore; Gwendolyn Michelle Gonzalez; Vikas Bansal; Yinsheng Wang; Christopher E Mason; Tariq M Rana
Journal:  Nat Microbiol       Date:  2016-02-22       Impact factor: 17.745

10.  Rapid and efficient purification of RNA-binding proteins: application to HIV-1 Rev.

Authors:  Marco Marenchino; David W Armbruster; Mirko Hennig
Journal:  Protein Expr Purif       Date:  2008-09-25       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.